Ibuprofen/Paracetamol Alkaloid-Int (Ibuprofen, Paracetamol)

Ibuprofen blocks cyclooxygenase enzymes, reducing peripheral prostaglandin production and thereby decreasing inflammation, pain and fever. Paracetamol works mainly in the central nervous system, inhibiting a variant of COX activity and influencing the endocannabinoid system to produce analgesic and antipyretic effects. Together they provide additive symptom control.

The appropriate dose is determined by the prescribing healthcare professional based on the patient’s age, weight, clinical condition and any concurrent medications. Patients should follow the prescriber’s instructions and the product labeling, and should not exceed the recommended maximum daily amount.

Safety in pregnancy and lactation has not been fully established for this combination. Healthcare providers generally advise caution and may recommend alternative therapies, especially in the first trimester or when breastfeeding. Patients should discuss any concerns with their physician before use.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

The combination offers complementary mechanisms: ibuprofen provides peripheral anti‑inflammatory action, while paracetamol adds central analgesic and antipyretic effects. This can result in better pain control and fever reduction at lower individual doses, potentially reducing the risk of side effects associated with higher doses of a single agent.

Store the tablets at ambient temperature, preferably below 25 °C. Keep them in the original container, protect from moisture and direct sunlight, and ensure they are out of reach of children.

The product is taken orally with a glass of water. It may be taken with or without food, although taking it with food can help minimise gastrointestinal discomfort. The exact dosing schedule should follow the prescriber’s guidance.

Serious risks include severe allergic reactions (anaphylaxis), gastrointestinal bleeding or ulceration, acute liver injury, and renal impairment. Patients should seek immediate medical attention if they experience symptoms such as rash, swelling, vomiting blood, dark stools, jaundice or sudden loss of kidney function.

Individuals with known hypersensitivity to ibuprofen, paracetamol, or any excipients should avoid the product. It is also contraindicated in patients with severe liver or kidney disease, active gastrointestinal ulceration, or those taking certain anticoagulants or other NSAIDs without medical supervision.